SCHEMBL18158611

SCHEMBL18158611

COc1cc2ncnc(Nc3ccc(O)cc3F)c2cc1OC

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.82
RET P07949 13/20 0.82
KIF5B P33176 11/20 0.82
FLT1 P17948 5/20 0.78
FGFR1 P11362 3/20 0.78
EGFR P00533 5/20 0.76
EPHB2 P29323 1/20 0.74
FLT4 P35916 1/20 0.74
GAK O14976 1/20 0.67
RIPK2 O43353 1/20 0.67
STK10 O94804 1/20 0.67
FLT3 P36888 1/20 0.67
JAK3 P52333 1/20 0.67
AAK1 Q2M2I8 1/20 0.67
Q6ZSR9 Q6ZSR9 1/20 0.67
SLK Q9H2G2 1/20 0.67
IRAK4 Q9NWZ3 1/20 0.67
RPS6KA6 Q9UK32 1/20 0.67
ALK Q9UM73 1/20 0.67
LCK P06239 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24245106 0.91 KDR (0.70) KDRRETKIF5BFLT1FGFR1
SCHEMBL7870603 0.90 KDR (1.00) KDRRETKIF5BFLT1FGFR1
Hydrochloric Acid SCHEMBL7867728 0.89 KDR (0.98) KDRRETKIF5BFLT1FGFR1
SCHEMBL5864787 0.88 RET (0.76) KDRRETKIF5BFLT1FGFR1
SCHEMBL18153625 0.86 RET (0.82) KDRRETKIF5BFLT1FGFR1
SCHEMBL7866068 0.86 KDR (0.80) KDRRETKIF5BFLT1FGFR1
SCHEMBL5864525 0.86 KDR (1.00) KDRRETKIF5BFLT1FGFR1
Hydrochloric Acid SCHEMBL18153626 0.85 KDR (0.80) KDRRETKIF5BFLT1FGFR1
SCHEMBL7113253 0.85 RET (0.82) KDRRETKIF5BFLT1FGFR1
Hydrochloric Acid SCHEMBL7870586 0.85 KDR (0.78) KDRRETKIF5BFLT1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10548897-B2 KSR antagonists ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2020-02-04 US disclosed
WO-2016168704-A1 KSR ANTAGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10548897-B2 KSR antagonists KSR1, KSR2, KRAS KDR 1123/4885RET 321/4885KIF5B 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.